Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Status: Publicly traded
Direct answer
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is publicly traded on HKSE under the ticker 9989.HK.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd., founded in 1998 and headquartered in Shenzhen, People's Republic of China, operates as an international pharmaceutical company. It is involved in the development, production, and distribution of a wide array of pharmaceutical goods, serving markets in Hong Kong, the United States, Europe, Mainland China, and other global regions. The company's operations are...
Can you invest in Shenzhen Hepalink Pharmaceutical Group Co., Ltd.?
Yes. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. trades publicly on HKSE as 9989.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Detailed equity research is provided by MarketSnap.